Liposomal daunorubicin (trade name DaunoXome) is a chemotherapy drug that is FDA approved to treat AIDS related Kaposi's sarcoma. It is also commonly used to treat specific types of leukaemia and non-Hodgkin lymphoma. Liposomal daunorubicin is intravenously administered. It utilizes the liposomal carrier system that provides a favorable pharmacokinetic profile at the site of KS lesions resulting in a 10-fold increase in concentrations compared to that which is achieved with conventional preparations.
liposomal, daunorubicin, trade, name, daunoxome, chemotherapy, drug, that, approved, treat, aids, related, kaposi, sarcoma, also, commonly, used, treat, specific, types, leukaemia, hodgkin, lymphoma, intravenously, administered, utilizes, liposomal, carrier, s. Liposomal daunorubicin trade name DaunoXome is a chemotherapy drug that is FDA approved to treat AIDS related Kaposi s sarcoma It is also commonly used to treat specific types of leukaemia and non Hodgkin lymphoma Liposomal daunorubicin is intravenously administered It utilizes the liposomal carrier system that provides a favorable pharmacokinetic profile at the site of KS lesions resulting in a 10 fold increase in concentrations compared to that which is achieved with conventional preparations See also editDaunorubicinExternal links editWomen amp Cancer Magazine Liposomal daunorubicin permanent dead link Johns Hopkins AIDS Service New from the Food and Drug Administration FDA DaunoXome Drugs com explanation nbsp This antineoplastic or immunomodulatory drug article is a stub You can help Wikipedia by expanding it vte Retrieved from https en wikipedia org w index php title Liposomal daunorubicin amp oldid 1053383164, wikipedia, wiki, book, books, library,
